- Report
- January 2025
- 200 Pages
Global
From €3979EUR$4,490USD£3,427GBP
- Report
- January 2025
- 175 Pages
Global
From €3979EUR$4,490USD£3,427GBP
- Report
- July 2025
- 377 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 228 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 594 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 207 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 279 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- July 2025
- 216 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- May 2025
- 187 Pages
Global
From €3390EUR$3,825USD£2,919GBP
€3988EUR$4,500USD£3,434GBP
- Report
- April 2025
- 200 Pages
Global
From €3979EUR$4,490USD£3,427GBP
- Report
- January 2025
- 284 Pages
Global
From €4431EUR$5,000USD£3,816GBP
- Report
- June 2025
- 400 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- May 2025
- 133 Pages
Global
From €4298EUR$4,850USD£3,701GBP
- Report
- September 2024
- 58 Pages
Asia Pacific
From €2880EUR$3,250USD£2,480GBP
- Report
- March 2025
- 120 Pages
North America
From €3013EUR$3,400USD£2,595GBP
€3545EUR$4,000USD£3,053GBP
- Report
- February 2024
- 468 Pages
Global
From €4253EUR$4,799USD£3,662GBP
- Report
- December 2023
- 353 Pages
Global
From €4387EUR$4,950USD£3,778GBP
- Report
- February 2024
- 67 Pages
Europe
From €2614EUR$2,950USD£2,251GBP
- Report
- February 2024
- 109 Pages
Global
From €4387EUR$4,950USD£3,778GBP
- Report
- January 2024
- 57 Pages
Asia Pacific
From €2614EUR$2,950USD£2,251GBP

Epigenomics is a field of genomics that studies the regulation of gene expression through chemical modifications of DNA and its associated proteins. It focuses on the heritable changes in gene expression that occur without changes in the underlying DNA sequence. These modifications, known as epigenetic marks, are involved in a variety of biological processes, including development, aging, and disease.
Epigenomics research has been used to identify biomarkers for cancer diagnosis and prognosis, as well as to develop new therapeutic strategies. It has also been used to study the effects of environmental factors on gene expression, such as nutrition, stress, and exposure to toxins.
The epigenomics market is expected to grow significantly in the coming years, driven by increasing investments in research and development, technological advancements, and the growing prevalence of cancer and other diseases.
Some companies in the epigenomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, Merck KGaA, and Oxford Nanopore Technologies. Show Less Read more